Chemistry: molecular biology and microbiology – Spore forming or isolating process
Patent
1986-03-10
1988-09-20
Tarcza, John E.
Chemistry: molecular biology and microbiology
Spore forming or isolating process
435 68, 435948, 436548, 530387, C12N 500, A61K 39395, G01N 3354, C12R 191
Patent
active
047725729
ABSTRACT:
Certain hybridomas preparing monoclonal antibodies to human interleukin-2 (IL-2) which do not cross react with rator mouse IL-2 are disclosed. The secreted monoclonal antibody can be used in immunoassays for human IL-2.
REFERENCES:
patent: 4473493 (1984-09-01), Gillis
patent: 4636463 (1987-01-01), Altman et al.
patent: 4690893 (1987-09-01), Mosmann
Gillis et al., "Generation of a B Cell Hybridoma Whose Antibody Product Inhibits Interleukin 2 Activity", Journal of Immunology 126(5), pp. 1978-84 (1981).
Stadler et al., "Human Interleukin-2: Biological Studies Using Purified IL-2 and Monoclonal Anti-IL-2 Antiobodies", Lymphokines 6, pp. 117-35 (1982).
Stadler et al., "Monoclonal Antibody Against Human Interleukin 2 (IL 2), Journal of Immunology 128(4), pp. 1620-4 (4-1982).
Hamuro Junji
Hanzawa Yoshiaki
Yoshimoto Ryota
Ajinomoto Co. Inc.
Tarcza John E.
LandOfFree
Hybridomas and monoclonal antibodies to human IL-2 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hybridomas and monoclonal antibodies to human IL-2, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hybridomas and monoclonal antibodies to human IL-2 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1748447